Related Experiment Video
Updated: Feb 1, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
[A multicenter clinical study on 1 138 cases of invasive pneumococcal disease in children from 2012 to 2017]
1Key Laboratory for Major Disease in Children, Ministry of Education, Department of Infectious Diseases, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China.
Insights
Invasive pneumococcal disease (IPD) in children is often community-acquired and severe, especially in those under five. The 13-valent pneumococcal conjugate vaccine (PCV13) shows promise in preventing IPD in Chinese children.
Area of Science:
- Pediatrics
- Infectious Diseases
- Microbiology
Background:
- Invasive pneumococcal disease (IPD) caused by Streptococcus pneumoniae (Spn) is a significant global health concern in children.
- Understanding the clinical spectrum, serotype distribution, and antimicrobial resistance patterns of IPD is crucial for effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the clinical features, serotype distribution, and drug resistance of Spn isolates in children with IPD.
- To identify independent risk factors associated with mortality in pediatric IPD cases.
Main Methods:
- A retrospective study analyzed laboratory data from 18 children's hospitals (2012-2017) for children with Spn isolated from sterile sites.
- Clinical characteristics, serotypes, drug resistance, treatment, and prognosis were reviewed, with mortality risk factors identified using multivariate logistic regression.
Main Results:
- 1,138 children with IPD were identified, predominantly under 5 years old (89.3%) and community-acquired (88.2%). Common infections included meningitis (39.2%) and pneumonia with bacteremia (29.8%).
- Penicillin non-susceptibility rates were high (69.5% in meningitis isolates). 93.8% of typed isolates were covered by PCV13.
- Mortality was 16.2% (156/965), with independent risk factors including age under 2, meningitis, underlying disease, septic shock, DIC, MOF, and CNS complications.
Conclusions:
- IPD in Chinese children primarily affects those under 5, often community-acquired and associated with underlying conditions.
- Meningitis, younger age, underlying diseases, and multiple organ failure are significant risk factors for IPD mortality.
- High drug resistance is a concern, but PCV13 vaccination is expected to be effective in preventing IPD in this population.
Abstract:
Objective: To explore the clinical features, the serotype distribution and drug resistance of the isolates in patient with invasive pneumococcal disease (IPD). Methods: By retrieving the laboratory information system in 18 children's hospitals from 2012 to 2017, the children with IPD were enrolled. Streptococcus pneumoniae (Spn) must be isolated from the sterile sites (blood, cerebrospinal fluid, hydrothorax and joint effusion etc.). The clinical characteristics, serotype, drug resistance, treatment and prognosis were reviewed and analyzed. According to the telephone follow up results, the patients were divided into death group and recovered group. The index as an independent risk factor of mortality was demonstrated by multivariate logistic regression analysis. Results: There were 1 138 children with IPD, including 684 male and 454 female. The proportion of male to female was 1.5∶1. The age ranged from one day to 16 years. The median age was 1 year 3 month. The majority was under 5 years of age (89.3%, n= 1 016), especially under 2 years of age (61.9%, n=704). In all cases, 88.2% (n=1 004) were community acquired infection. The infections included meningitis (n=446, 39.2%), pneumonia with bacteremia (n=339, 29.8%), and bacteremia without focus (n=232, 20.4%). Underlying diseases were found in 242 cases (21.3%). Co-infections were determined in 62 cases (5.4%) with mycoplasma, 27 cases (2.4%) with adenovirus and 34 cases with influenza virus (3.0%). The penicillin insensitivity (PNSP) rates in meningitis and non-meningitis isolates were 69.5% (276/397) and 35.9% (221/615), respectively. There were 81 strains serotyped, in which 93.8% (76/81) were covered by 13-valent protein-polysaccharide conjugate vaccine (PCV13). In the 965 patients who were followed up by phone call, 156 cases (16.2%) were confirmed dead. The independent risk factors for the death were under 2 years of age (OR=2.143, 95%CI 1.284-3.577, P=0.004), meningitis (OR=3.066, 95%CI 1.852-5.074, P<0.01), underlying disease (OR=4.801, 95%CI 2.953-7.804, P<0.01), septic shock(OR=3.542, 95%CI 1.829-6.859, P<0.01), disseminated intravascular coagulation (DIC) (OR=4.150, 95%CI 1.468-11.733, P=0.007), multiple organ failure (OR=12.693, 95%CI 6.623-24.325, P<0.01) and complications of central nervous system (OR=1.975, 95%CI 1.144-3.410, P=0.015). Conclusions: Most children with IPD were under 5 years of age, having underlying diseases and acquired the infection in community. The independent risk factors for death were under two years old, meningitis, underlying diseases and multiple organ failure. The problem of drug resistance was severe. The universal immunization of PCV13 would be effective to prevent IPD in Chinese children.
More Related Videos
14:45Enumeration of Major Peripheral Blood Leukocyte Populations for Multicenter Clinical Trials Using a Whole Blood Phenotyping Assay
Published on: September 16, 2012
09:20Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Kidney Disease II: Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation